CIK 0001878313
- Emerging growth company
MAIA Biotechnology, Inc.
Sign in to watch- Ticker
- MAIA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 312-416-8592
- Business address
- 444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
- Open-market buys, last 90 days
- $536,016
- in 6 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$536,016. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-04 | Vitoc Vlad Chief Executive Officer | Purchase | +1,266 | $3.68 | $5K | 793,121 |
| 2023-01-03 | Vitoc Vlad Chief Executive Officer | Purchase | +2,324 | $3.64 | $8K | 791,855 |
| 2022-12-30 | Louie Ngar Yee Director | Grant or award · Stock Options | +4,568 | 4,568 | ||
| 2022-12-30 | CHAOUKI STEVEN M Director | Grant or award · Stock Options | +3,045 | 3,045 | ||
| 2022-12-30 | Smith Stan Director | Grant or award · Stock Options | +3,807 | 3,807 | ||
| 2022-12-30 | Guerrero Ramiro Director | Grant or award · Stock Options | +3,045 | 3,045 | ||
| 2022-12-30 | Luput Cristian Director | Grant or award · Stock Options | +3,045 | 3,045 | ||
| 2022-12-30 | Vlad Laurentiu Director | Grant or award · Stock Options | +3,045 | 3,045 | ||
| 2022-12-30 | Vitoc Vlad Chief Executive Officer | Purchase | +410 | $3.50 | $1K | 789,531 |
| 2022-12-30 | Smith Stan Director | Purchase | +500 | $3.50 | $2K | 513,328 |
| 2022-12-29 | Smith Stan Director | Purchase | +1,471 | $3.49 | $5K | 512,828 |
| 2022-12-28 | Smith Stan Director | Purchase | +1,266 | $3.41 | $4K | 511,357 |
| 2022-12-27 | Smith Stan Director | Purchase | +604 | $3.38 | $2K | 510,091 |
| 2022-12-23 | Smith Stan Director | Purchase | +981 | $3.45 | $3K | 509,487 |
| 2022-12-22 | Smith Stan Director | Purchase | +731 | $3.34 | $2K | 508,506 |
| 2022-12-21 | Smith Stan Director | Purchase | +399 | $3.43 | $1K | 507,775 |
| 2022-12-20 | Smith Stan Director | Purchase | +4,048 | $3.53 | $14K | 507,376 |
| 2022-12-07 | Gryaznov Sergei Chief Scientific Officer | Exercise or conversion | +10,000 | $1.83 | $18K | 44,511 |
| 2022-12-07 | Gryaznov Sergei Chief Scientific Officer | Exercise or conversion · Stock Options | −10,000 | 40,000 | ||
| 2022-09-19 | Smith Stan Director | Purchase | +2,700 | $3.69 | $10K | 1,424,178 |
Page 15 of 17 · 323 trades